Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 7;15(27):10448-10454.
doi: 10.1039/d4sc02985b. eCollection 2024 Jul 10.

Controlling rates and reversibilities of elimination reactions of hydroxybenzylammoniums by tuning dearomatization energies

Affiliations

Controlling rates and reversibilities of elimination reactions of hydroxybenzylammoniums by tuning dearomatization energies

Zihuan Fu et al. Chem Sci. .

Abstract

Hydroxybenzylammonium compounds can undergo a reversible 1,4- or 1,6-elimination to afford quinone methide intermediates after release of the amine. These molecules are useful for the reversible conjugation of payloads to amines. We hypothesized that aromaticity could be used to alter the rate of reversibility as a distinct thermodynamic driving force. We describe the use of density functional theory (DFT) calculations to determine the effect of aromaticity on the rate of release of the amine from hydroxybenzylammonium compounds. Namely, the aromatic scaffold affects the dearomatization reaction to reduce the kinetic barrier and prevent the reversibility of the amine elimination. We consequently synthesized a small library of polycyclic hydroxybenzylammoniums, which resulted in a range of release half-lives from 18 minutes to 350 hours. The novel mechanistic insight provided herein significantly expands the range of release rates amenable to hydroxybenzylammonium-containing compounds. This work provides another way to affect the rate of payload release in hydroxybenzylammoniums.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1. (a) Benzyl carbamates for amine release. (b) Hydroxybenzylammoniums with electron-donating groups and intramolecular trapping arms. (c) Polycyclic azaquinone methide-mediated release of benzylic phenols. (d) Polycyclic aromatic hydroxybenzylammoniums. Star indicates a potential payload of interest (fluorophore, polymer, protein/peptide, etc.).
Fig. 2
Fig. 2. (a) Free energy diagrams for polycyclic aromatic hydroxybenzylammonium release calculated at the M06-2X/aug-cc-pVTZ, CPCM(Water)//B3LYP-D3/6-31+G(d,p), CPCM(Water) level of theory. (b) TS1 geometries calculated for 1,4-benzene, 1,4-naphthalene, 1,4-anthracene, and 9,10-anthracene-based hydroxybenzylammoniums. (c) Calculated free energy of activation at the aforementioned level of theory plotted against the corresponding Polansky Aromaticity Index of the parent hydrocarbon scaffold.
Scheme 1
Scheme 1. Synthesis of 1,4-anthracene hydroxybenzaldehyde 8.
Fig. 3
Fig. 3. (a) Library of polycyclic aromatic–phenethylamine conjugates prepared and their experimentally determined release rate constants. (b) Phenethylamine release kinetics of 1, 2a, and 3a (n = 3, some error bars are smaller than markers) carried out at 5 mM of the benzene- or naphthalene-hydroxybenzylammoniums or 1 mM of the anthracene-hydroxybenzylammonium in a 1 : 1 mixture of methanol and 0.1 M Tris buffer (pH 7.4). (c) First-order plot of phenethylamine release kinetics of 2a and 3a (n = 3, some error bars are smaller than markers).
Fig. 4
Fig. 4. (a) TS1 structures calculated at the B3LYP-D3/6-31+G(d,p), CPCM(water) level of theory for 5- and 8-hydroxyquinoline benzylammoniums and calculated free energies of activation for the forward and reverse reactions at the M06-2X/aug-cc-pVTZ, CPCM(Water)//B3LYP-D3/6-31+G(d,p), CPCM(Water) level of theory. (b) Library of pyridine-, quinoline-, and azanaphthalene-based phenethylamine conjugates synthesized and their experimentally determined release rate constants. (c) First-order plot of phenethylamine release kinetics (n = 3, some error bars are smaller than markers) carried out at 5 mM of the hydroxy- or azabenzylammonium in a 1 : 1 mixture of methanol and 0.1 M Tris buffer (pH 7.4).
Fig. 5
Fig. 5. Release half-life spectrum of hydroxybenzylammonium molecules. Release half-lives displayed are from this report as well as our previous article.

Similar articles

  • Short-Term Memory Impairment.
    Cascella M, Al Khalili Y. Cascella M, et al. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
  • Sexual Harassment and Prevention Training.
    Cedeno R, Bohlen J. Cedeno R, et al. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Mar 29. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36508513 Free Books & Documents.
  • Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N, Hartmann-Boyce J, Fanshawe TR, Begh R, Farley A, Lancaster T. Lindson-Hawley N, et al. Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3. Cochrane Database Syst Rev. 2016. PMID: 27734465 Free PMC article.
  • Fabricating mice and dementia: opening up relations in multi-species research.
    Davies G, Gorman R, Milne R. Davies G, et al. In: Jenkins N, Jack-Waugh A, Ritchie L, editors. Multi-Species Dementia Studies. Bristol (UK): Bristol University Press; 2025 Feb 25. Chapter 2. In: Jenkins N, Jack-Waugh A, Ritchie L, editors. Multi-Species Dementia Studies. Bristol (UK): Bristol University Press; 2025 Feb 25. Chapter 2. PMID: 40690569 Free Books & Documents. Review.
  • Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.
    Johnson WD, Diaz RM, Flanders WD, Goodman M, Hill AN, Holtgrave D, Malow R, McClellan WM. Johnson WD, et al. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD001230. doi: 10.1002/14651858.CD001230.pub2. Cochrane Database Syst Rev. 2008. PMID: 18646068

References

    1. Peleg-Shulman T. Tsubery H. Mironchik M. Fridkin M. Schreiber G. Shechter Y. Reversible PEGylation: A Novel Technology To Release Native Interferon α2 over a Prolonged Time Period. J. Med. Chem. 2004;47:4897–4904. doi: 10.1021/jm0497693. - DOI - PubMed
    1. Erez R. Shabat D. The azaquinone-methide elimination: comparison study of 1,6- and 1,4-eliminations under physiological conditions. Org. Biomol. Chem. 2008;6:2669–2672. doi: 10.1039/B808198K. - DOI - PubMed
    1. Lee S. Greenwald R. B. McGuire J. Yang K. Shi C. Drug Delivery Systems Employing 1,6-Elimination: Releasable Poly(ethylene glycol) Conjugates of Proteins. Bioconjugate Chem. 2001;12:163–169. doi: 10.1021/bc000064z. - DOI - PubMed
    1. Dubowchik G. M. Firestone R. A. Cathepsin B-sensitive dipeptide prodrugs. 1. A model study of structural requirements for efficient release of doxorubicin. Bioorg. Med. Chem. Lett. 1998;8:3341–3346. doi: 10.1016/S0960-894X(98)00609-X. - DOI - PubMed
    1. Dubowchik G. M. Mosure K. Knipe J. O. Firestone R. A. Cathepsin B-sensitive dipeptide prodrugs. 2. Models of anticancer drugs paclitaxel (Taxol®), mitomycin C and doxorubicin. Bioorg. Med. Chem. Lett. 1998;8:3347–3352. doi: 10.1016/S0960-894X(98)00610-6. - DOI - PubMed